Arvinas, Inc. (ARVN)
7.46
+0.05
(+0.67%)
USD |
NASDAQ |
Oct 05, 16:00
7.46
0.00 (0.00%)
Pre-Market: 09:03
Arvinas Max Drawdown (5Y) : 94.37% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 94.37% |
| August 31, 2026 | 94.37% |
| July 31, 2026 | 94.37% |
| June 30, 2026 | 94.37% |
| May 31, 2026 | 94.37% |
| April 30, 2026 | 94.37% |
| March 31, 2026 | 94.37% |
| February 28, 2026 | 94.37% |
| January 31, 2026 | 94.37% |
| December 31, 2025 | 94.37% |
| November 30, 2025 | 94.37% |
| October 31, 2025 | 94.37% |
| September 30, 2025 | 94.37% |
| August 31, 2025 | 94.37% |
| July 31, 2025 | 94.37% |
| June 30, 2025 | 94.37% |
| May 31, 2025 | 94.37% |
| April 30, 2025 | 94.26% |
| March 31, 2025 | 93.49% |
| February 28, 2025 | 86.85% |
| January 31, 2025 | 86.85% |
| December 31, 2024 | 86.85% |
| November 30, 2024 | 86.85% |
| October 31, 2024 | 86.85% |
| September 30, 2024 | 86.85% |
| Date | Value |
|---|---|
| August 31, 2024 | 86.85% |
| July 31, 2024 | 86.85% |
| June 30, 2024 | 86.85% |
| May 31, 2024 | 86.85% |
| April 30, 2024 | 86.85% |
| March 31, 2024 | 86.85% |
| February 29, 2024 | 86.85% |
| January 31, 2024 | 86.85% |
| December 31, 2023 | 86.85% |
| November 30, 2023 | 86.85% |
| October 31, 2023 | 86.85% |
| September 30, 2023 | 81.79% |
| August 31, 2023 | 79.86% |
| July 31, 2023 | 79.86% |
| June 30, 2023 | 79.86% |
| May 31, 2023 | 79.76% |
| April 30, 2023 | 76.54% |
| March 31, 2023 | 75.76% |
| February 28, 2023 | 73.51% |
| January 31, 2023 | 73.51% |
| December 31, 2022 | 69.90% |
| November 30, 2022 | 66.62% |
| October 31, 2022 | 66.62% |
| September 30, 2022 | 66.62% |
| August 31, 2022 | 66.62% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Cocrystal Pharma, Inc. | 97.93% |
| CNBX Pharmaceuticals, Inc. | 100.0% |
| Fulcrum Therapeutics, Inc. | 92.70% |
| Definium Therapeutics, Inc. | 96.96% |
| LeonaBio, Inc. | 99.33% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -59.51 |
| Beta (5Y) | 1.805 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 71.06% |
| Historical Sharpe Ratio (5Y) | -0.5833 |
| Historical Sortino (5Y) | -1.029 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.08% |